Skip to content

Answer

Zepbound savings card: who it pays and how much

9 documents cited · Read September 2026

The short answer

Only with commercial insurance. If your plan covers the Zepbound pen, you can pay as little as $25 a fill. If it doesn't, the card sets a cash price instead. Medicare, Medicaid, TRICARE and VA members can't use it.

Which Zepbound card are you actually holding?

Lilly runs one savings program with three different prices behind it, and which one you get depends on your insurance and on the form of Zepbound on your prescription. Check the drug name on your prescription first: the single-dose pen and the KwikPen are separate products with separate rules.

Vials aren't covered by any of the cards. The terms name the eligible pens and say other forms aren't eligible, and LillyDirect sells the vial as self-pay only.

The Zepbound savings card, by situation
Your situationWhat you payLimits
Plan covers the single-dose penAs little as $25 a fillSavings up to $100 a month, $1,300 a year, 13 fills
Plan doesn't cover the single-dose penAs low as $499 a month13 fills a year
Plan doesn't cover the KwikPen$299 to $449 a month, by dose11 fills a year; refill within 45 days at 7.5 mg and up

Read on Lilly's Zepbound savings page in September 2026. Every card expires December 31, 2026.

What does the card pay if your plan covers Zepbound?

If your commercial plan covers the single-dose pen, you can pay as little as $25 for a one-, two- or three-month fill. The card pays the rest up to a cap: $100 for a one-month fill, $200 for two months, $300 for three, and $1,300 a year across up to 13 fills.

So $25 isn't guaranteed. If your share of the bill is more than $25 plus the card's $100 monthly cap, you pay the rest.

The covered price only works when your plan actually pays the claim. If the plan hasn't approved Zepbound for you yet, there's nothing for the card to reduce.

What does it do if your plan doesn't cover Zepbound?

It stops being a discount on a copay and becomes a cash price. For the single-dose pen, the terms say you can pay as low as $499 for a one-month fill.

For the KwikPen, the price depends on the dose: $299 at 2.5 mg, $399 at 5 mg and $449 from 7.5 mg up. That $449 holds only if you refill within 45 days. Miss the window and the regular price applies, which is $499 at 7.5 mg and $699 at 10, 12.5 and 15 mg.

Those KwikPen prices match what LillyDirect charges for cash. Through LillyDirect the discount is applied for you; at another pharmacy you need the card.

Why can't you use it on Medicare, Medicaid, TRICARE or VA?

The terms exclude anyone enrolled in a government-funded health program: Medicaid, Medicare, Part D, Medicare Advantage, Medigap, DoD, VA and TRICARE among them. The reason is federal law. The HHS Office of Inspector General has said a manufacturer coupon on a drug a federal program pays for implicates the anti-kickback statute.

You still have two routes. Lilly's separate self-pay KwikPen card is for cash patients, and its eligibility list has no government-program exclusion; Lilly's savings page offers it under Medicare and other government choices. If you're on Medicare Part D, the GLP-1 Bridge covers the Zepbound KwikPen for weight loss at a $50 monthly copay if you qualify.

Paying cash has a cost of its own: under the self-pay terms, what you spend can't count toward a deductible or out-of-pocket limit.

Why did the pharmacy reject your card?

Most rejections trace back to one of five things. Work through them in order before you pay full price.

  1. The card isn't activated. The terms say activation is required, and an unactivated card won't process.

  2. Your plan doesn't cover the form you were prescribed. Express Scripts' national formulary excludes the KwikPen and the vial and prefers the pen; Optum Rx's Premium list excludes the KwikPen and the vial too. The covered-plan price needs your plan to cover the product on the prescription.

  3. You're flagged as having government coverage. If you have Medicare, Medicaid, TRICARE or VA coverage alongside a job-based plan, the terms exclude you.

  4. Your plan uses an alternate funding program. The terms bar you from the card if your plan participates in one.

  5. You were prescribed the vial. No savings card covers it; it's sold self-pay through LillyDirect.

Should you use the card or just pay LillyDirect's cash price?

If your plan covers the pen, use the card: $25 beats any cash price. If your plan excludes Zepbound, compare the KwikPen price at your dose with the single-dose pen's $499. The KwikPen is lower at every dose as long as you refill within 45 days; miss that window and the top three doses cost $699, more than the pen. LillyDirect charges the same KwikPen prices and applies the discount for you.

Before you pay cash, ask your plan for a formulary exception. A covered prescription is almost always cheaper, and an exception costs you nothing but a phone call from your prescriber's office.

What to say to the pharmacy or the savings program

I have a Zepbound savings card and commercial insurance. Can you tell me whether the claim went to my plan first, and what the plan paid? Is the card activated? Which Zepbound product is on my prescription: the single-dose pen, the KwikPen or the vial?

The savings program's number is 1-866-923-1953. Write down the name of the person you spoke with, the date, and any rejection code the pharmacy gives you.

Every claim above, with the document behind it

If something here decides anything for you, read the source rather than our summary of it. These are the documents we opened, and the month we opened them.

If your commercial plan covers the Zepbound single-dose pen, the card terms say you may "pay as little as $25 for a 1-month, 2-month, or 3-month prescription fill," with "maximum monthly savings of up to $100 per 1-month prescription, $200 per 2-month prescription, or $300 per 3-month prescription fill and a separate maximum annual savings of up to $1,300 per calendar year. Card may be used for a maximum of up to 13 prescription fills per calendar year." A month is "28-days and up to 4 single-dose pens."

Eli Lilly and Company, Zepbound Savings Card terms and conditions, effective August 2026 · source

If your commercial plan does not cover the single-dose pen, the card terms say you may "pay as low as $499 for your 1-month prescription fill", with "maximum monthly savings based on wholesale acquisition cost minus $499, up to a maximum of 13 prescription fills per calendar year."

Eli Lilly and Company, Zepbound Savings Card terms and conditions, effective August 2026 · source

For a commercially insured patient whose plan "does not provide coverage for Zepbound single-patient-use KwikPen", the card terms set these prices for a 28-day fill of one KwikPen: 2.5 mg "Pay as low as $299", 5 mg $399, 7.5 mg $449, and 10, 12.5 and 15 mg $449. The card "may be used for a maximum of up to 11 prescription fills per calendar year." The $449 price at 7.5 mg and above requires you to "complete your refill purchase… within 45 days"; otherwise the "Regular price" is "$299 for 2.5 mg, $399 for 5 mg, $499 for 7.5 mg, $699 for 10 mg, $699 for 12.5 mg, and $699 for 15 mg."

Eli Lilly and Company, Zepbound Savings Card terms and conditions, effective August 2026 · source

Lilly's Zepbound savings card terms require that "You are not enrolled in any state, federal, or government funded healthcare program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE®/CHAMPUS, or any state prescription drug assistance program." You must also be "a resident of the United States or Puerto Rico" and "18 years of age or older."

Eli Lilly and Company, Zepbound Savings Card terms and conditions, effective August 2026 · source

The terms list the eligible single-dose pen and KwikPen products and then state: "Other methods of administration are not eligible for Program savings." Every card "expires and savings end on 12/31/2026." "Card activation is required," the card "cannot be combined or utilized with any other program, discount", and "THIS CARD IS NOT INSURANCE." The program's phone number is 1-866-923-1953.

Eli Lilly and Company, Zepbound Savings Card terms and conditions, effective August 2026 · source

"If you have an insurance plan that is participating in an alternate funding program or similar program ('AFP')… you are not eligible for and are prohibited from using the… Savings Card Program." Lilly also "may reduce, eliminate, or otherwise modify the Card savings" if your plan "removes coverage for Zepbound and requires you to utilize the Card… or does not apply Card payments to satisfy your co-payment, deductible, or coinsurance for Zepbound."

Eli Lilly and Company, Zepbound Savings Card terms and conditions, effective August 2026 · source

The separate self-pay KwikPen card "is for self‑paying (cash) patients only": you agree that you "will not seek or accept reimbursement… from any third‑party payer, including private insurance or state or federal healthcare programs, nor apply those costs toward any deductible or true out‑of‑pocket requirements." Its eligibility list is residency in the United States or Puerto Rico and age 18 or older, with the same $299, $399 and $449 prices and "a maximum of up to 11 prescription fills per calendar year." On Lilly's savings page this option appears under the Medicare, "Government (other)" and "No insurance" choices.

Eli Lilly and Company, Zepbound self-pay KwikPen terms and conditions, effective August 2026 · source · savings page

LillyDirect lists the Zepbound KwikPen and the Zepbound vial each "Starting at $299/month", then $399 and $449 by dose, with the $449 price at 7.5 mg and above "with Zepbound Journey Program. Regular prices will apply if prescription is not refilled within 45 days ($499 for 7.5mg, $699…)". It lists the vial as "Exclusively available through LillyDirect | Self-pay only", and the single-dose pen as "Insurance accepted", "Pay as low as $25* per month for up to a 3-month prescription." It adds: "Savings are automatically applied through LillyDirect. If you choose to fill through another pharmacy, you may need a Lilly savings program depending on your insurance type."

Eli Lilly and Company, LillyDirect: Zepbound, effective August 2026 · source

The HHS Office of Inspector General, September 2014: "When the item in question is one for which payment may be made, in whole or in part, under a Federal health care program (including Medicare Part D), the anti-kickback statute is implicated." It adds that "Copayment coupons typically bear a statement that the coupon may not be used by beneficiaries of Federal health care programs."

HHS Office of Inspector General, Special Advisory Bulletin: Pharmaceutical Manufacturer Copayment Coupons, effective September 2014 · source

CMS: "an eligible GLP-1 drug is any of the following products when used to reduce excess body weight and maintain weight reduction: Foundayo®, Wegovy® (injection and tablets), and Zepbound® (KwikPen®)." The page notes: "This was updated on April 6, 2026, to include Foundayo® following FDA approval."

Centers for Medicare & Medicaid Services, Medicare GLP-1 Bridge: information for Part D plans, effective August 2026 · source

CMS: the Bridge gives access "between July 1, 2026, and December 31, 2027." "Eligible beneficiaries will have a $50 copay … the Part D deductible will not apply, no part of the $50 copay counts towards the beneficiary's TrOOP costs, and there is no low-income subsidy (LIS) provided for LIS beneficiaries."

Centers for Medicare & Medicaid Services, Medicare GLP-1 Bridge, effective July 2026 · source

Express Scripts' 2026 National Preferred Formulary exclusions list (footer "EXCL-NPF-26 (07/01/2026)") lists, under Weight Loss, the excluded drugs "ZEPBOUND KWIKPENS, ZEPBOUND VIALS" and the preferred alternatives "liraglutide, FOUNDAYO, WEGOVY HD, WEGOVY PENS, WEGOVY TABLETS, ZEPBOUND PENS." It adds: "Not all the medications listed are covered by all prescription plans; check your benefit materials."

Express Scripts, 2026 National Preferred Formulary Exclusions, effective July 2026 · source

Optum Rx's Premium Standard formulary effective July 1, 2026 lists "WEGOVY 2 PA; ++; QL", the Zepbound subcutaneous solution auto-injector at "2 PA; ++; QL", and "ZEPBOUND KWIKPEN E" and the Zepbound subcutaneous solution (vial) at "E". Its legend defines "++" as "Benefit design options – Coverage is determined by your prescription medication benefit plan."

Optum Rx, Premium Standard Formulary, effective July 1, 2026, effective July 2026 · source

Where this comes from

  1. Eli Lilly and Company, Zepbound Savings Card terms and conditions, effective August 2026 — Open the document
  2. Eli Lilly and Company, Zepbound self-pay KwikPen terms and conditions, effective August 2026 — Open the document
  3. Eli Lilly and Company, Zepbound savings page — Open the document
  4. Eli Lilly and Company, LillyDirect: Zepbound, effective August 2026 — Open the document
  5. HHS Office of Inspector General, Special Advisory Bulletin: Pharmaceutical Manufacturer Copayment Coupons, effective September 2014 — oig.hhs.gov/documents/special-advisory-bulletins/878/SAB_Copayment_Coupo
  6. Centers for Medicare & Medicaid Services, Medicare GLP-1 Bridge: information for Part D plans, effective August 2026 — www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-
  7. Centers for Medicare & Medicaid Services, Medicare GLP-1 Bridge, effective July 2026 — www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-
  8. Express Scripts, 2026 National Preferred Formulary Exclusions, effective July 2026 — Open the document
  9. Optum Rx, Premium Standard Formulary, effective July 1, 2026, effective July 2026 — Open the document

Where to go next

American GLP is not a law firm, an insurer, a government office or a clinician, and nothing here is legal or medical advice. This page describes what published rules say. Your own plan documents and your own notice govern your case, and rules change — check the sources before you act.